Influenza A virus A/Switzerland/9715293/2013 (H3N2) live (attenuated) antigen Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections Health Services Research

Indications	Status	Purpose	Phase
DBCOND0035016 (Human Immunodeficiency Virus (HIV) Infections)	Completed	Health Services Research	2

clinicaltrials.gov Identifier	Title	Drugs
NCT02474901	Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults	Influenza A virus A/Bolivia/559/2013 (H1N1) live (attenuated) antigen (DB11034) Influenza A virus A/Switzerland/9715293/2013 (H3N2) live (attenuated) antigen (DB11035) Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen (DB11037) Influenza B virus B/Phuket/3073/2013 live (attenuated) antigen (DB11036)